United States: Federal Circuit Patent Updates - December 2014

Last Updated: December 31 2014
Article by WilmerHale

View previous updates...

Aqua Shield v. Interpool Pool Cover Team (No. 2014-1263, 12/22/14) (Wallach, Taranto, Chen)

December 22, 2014 6:15 PM

Taranto, J. Vacating royalty award, non-willfulness finding, and denial of enhanced damages and attorney's fees and remanding. Regarding damages, "[i]f a potential user of the patented technology would expect to earn X profits in the future without using the patented technology, and X + Y profits by using the patented technology, it would seem, as a prima facie matter, economically irrational to pay more than Y as a royalty—paying more would produce a loss compared to forgoing use of the patented technology... [T]he district court did not err in considering [defendant's] profits. But it did err in treating the profits [defendant] actually earned during the period of infringement as a royalty cap. That treatment incorrectly replaces the hypothetical inquiry into what the parties would have anticipated, looking forward when negotiating, with a backward-looking inquiry into what turned out to have happened."

A full version of the text is available in PDF form.

Creative Kingdoms, LLC v. ITC (No. 2014-1072, 12/19/14) (Newman, Bryson, O'Malley)

December 19, 2014 4:10 PM

Affirming finding of no Section 337 violation. "Here, the novelty of the asserted claims includes the use of sensors in combination, and the scope of the asserted claims includes both mechanical and electronic sensors. But the two specifications contain no guidance as to how electronic sensors, such as accelerometers and gyroscopes, can be substituted or added to detect different motions, as required by the asserted claims. Instead, the specifications merely include a laundry list of the types of electronic sensors that could be used... Without any further guidance, the specifications fail to disclose how to make and use the full scope of the asserted claims. Accordingly, the asserted claims are invalid for lack of enablement."

A full version of the text is available in PDF form.

Stryker Corporation v. Zimmer, Inc. (No. 2013-1668, 12/19/14) (Prost, Newman, Hughes)

December 19, 2014 1:22 PM

Prost, J. Affirming jury's findings of validity and infringement of patents related to pulsed lavage devices and also affirming summary judgment of infringement of another patent. Also affirming jury's damages award and reversing judgment of willful infringement and award of treble damages. "An objective assessment of the case shows that [defendant] presented reasonable defenses to all of the asserted claims of [the] patents." Also vacating finding of exceptional case and award of attorneys' fees and remanding.

A full version of the text is available in PDF form.

University of Utah Research v. Ambry Genetics Corporation (No. 2014-1361, -1366, 12/17/14) (Prost, Clevenger, Dyk)

December 17, 2014 11:30 AM

Dyk, J. Affirming denial of preliminary injunction and finding invalid under §101 claims related to BRCA gene sequences. Although this case presented different claims, some of the asserted patents were previously considered by the Supreme Court in Association for Molecular Pathology v. Myriad Genetics, Inc. Following Myriad, the Court found the structure claims invalid. "Contrary to [patent owner's] statement, it makes no difference that the identified gene sequences are synthetically replicated. As the Supreme Court made clear, neither naturally occurring compositions of matter, nor synthetically created compositions that are structurally identical to the naturally occurring compositions, are patent eligible." The Court found the method claims invalid following Alice Corp. v. CLS Bank Int'l. The method claims were directed to "the patent-ineligible abstract idea of comparing BRCA sequences and determining the existence of alterations" and the non-patent-ineligible elements of those claims "set forth well-understood, routine and conventional activity engaged in by scientists at the time of [patent owner's] patent applications.".

A full version of the text is available in PDF form.

Promega Corp v. Life Tech (No. 2013-1011, -1029, -1376, 12/15/14) (Prost, Mayer, Chen)

December 15, 2014 3:20 PM

Chen, J. Reversing grant of JMOL of non-infringement for patent related to DNA-based identification. The Court concluded that no third party is required to satisfy the "to actively induce the combination" language of §271(f)(1). The Court also held "that there are circumstances in which a party may be liable under §271(f)(1) for supplying ... a single component for combination outside the United States." Also reversing denial of summary judgment and finding invalid other patents due to lack of enablement, affirming ruling that some sales were not covered by a cross license, vacating damages award and remanding. Prost, J. dissented-in-part and would have found that §271(f)(1) requires inducement of a third party.

WilmerHale represented the plaintiff-cross-appellant, Promega Corporation.

A full version of the text is available in PDF form.

Japanese Foundation v. Lee (No. 2013-1678, 2014-1014 12/9/14) (Prost, Dyk, Taranto)

December 9, 2014 10:15 AM

Prost, J. Vacating order that the PTO withdraw a terminal disclaimer.

A full version of the text is available in PDF form.

Memorylink Corp. v. Motorola Solutions, Inc. (No. 2014-1186, 12/5/14) (Lourie, Moore, O'Malley)

December 5, 2014 1:45 PM

Lourie, J. Affirming summary judgment that assignment of invention was valid and did not lack consideration and dismissing tort claims as barred under the statute of limitations.

A full version of the text is available in PDF form.

Sandoz, Inc. v. Amgen, Inc. (No. 2014-1693, 12/5/14) (Dyk, Taranto, Chen)

December 5, 2014 9:30 AM

Taranto, J. Affirming district court's denial of declaratory judgment jurisdiction where, when suit was filed, plaintiff was conducting phase III trials for biosimilar product and FDA approval was at least several years away.

A full version of the text is available in PDF form.

DDR Holdings, LLC v. Hotels.com, L.P. (No. 2013-1505, 12/5/14) (Wallach, Mayer, Chen)

December 5, 2014 4:22 PM

Chen, J. Affirming finding that one patent direct to directed to systems and methods of generating a composite website claimed patentable subject matter and that the claim term "look and feel" was not indefinite. A second patent was found invalid as anticipated. Mayer, J., partially dissented on the 101 holding.

A full version of the text is available in PDF form.

Tyco Healthcare Grp. LP v. Ethicon Endo-Surgery, Inc. (No. 2013-1324, -1381, 12/4/14) (Prost, Reyna, Hughes)

December 4, 2014 12:40 PM

Prost, J. Reversing obviousness determination of district court where district court correctly found prior invention under 35 U.S.C. 102(g) but did not apply it under Section 103.

A full version of the text is available in PDF form.

Ericsson, Inc. v. D-Link Systems, Inc. (No. 2013-1625, -1631, -1632, -1633, 12/4/14) (O'Malley, Taranto, Hughes)

December 4, 2014 11:15 AM

O'Malley, J. Affirming in part and reversing in part judgment in favor of patentee on patents alleged to be essential to practicing Wi-Fi standard. With respect to one patent, denial of JMOL affirmed because claim language recited the capability of a device rather than its operation. With respect to a second patent, although it would have been a "factual error" to find direct infringement of a method claim, a verdict covering both direct and indirect infringement was sustained where the jury could have found induced infringement. With respect to damages the Court held (1) it was not error to admit licenses that applied a royalty to a royalty base that did not comply with the entire market value rule, (2) argument by counsel referring to the total cost of a laptop when discussing the requested royalty rate was not objected to at trial and therefore would not be reviewed (3) the district court's instructions with respect to damages for standards-essential patents were erroneous. "In sum, we hold that, in all cases, a district court must instruct the jury only on factors that are relevant to the specific case at issue. There is no Georgia-Pacific-like list of factors that district courts can parrot for every case involving RAND-encumbered patents. The court should instruct the jury on the actual RAND commitment at issue and must be cautious not to instruct the jury on any factors that are not relevant to the record developed at trial. We further hold that district courts must make clear to the jury that any royalty award must be based on the incremental value of the invention, not the value of the standard as a whole or any increased value the patented feature gains from its inclusion in the standard. We also conclude that, if an accused infringer wants an instruction on patent hold-up and royalty stacking, it must provide evidence on the record of patent hold-up and royalty stacking in relation to both the RAND commitment at issue and the specific technology referenced therein." Taranto, J., partially dissented on an infringement holding.

WilmerHale represented the intervenor-appellant Intel and argued for the appellants.

A full version of the text is available in PDF form.

Par Pharmaceuticals, Inc. v. TWI Pharmaceuticals, Inc. (No. 2014-1391, 12/3/14) (O'Malley, Wallach, Hughes)

December 3, 2014 3:40 PM

O'Malley, J. Reversing and remanding finding that method of treatment claims were obvious where district court had misapplied law of inherency. "A party must . . . meet a high standard in order to rely on inherency to establish the existence of a claim limitation in the prior art in an obviousness analysis—the limitation at issue necessarily must be present, or the natural result of the combination of elements explicitly disclosed by the prior art." The Court otherwise affirmed the district court's findings of motivation to combine, reasonable expectation of success and absence of unexpected results.

A full version of the text is available in PDF form.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Similar Articles
Relevancy Powered by MondaqAI
In association with
Related Topics
Similar Articles
Relevancy Powered by MondaqAI
Related Articles
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions